DIGESTIVE SYSTEM - 4 Emma Jakoi
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
The Baseline Structure of the Enteric Nervous System and Its Role in Parkinson’S Disease
life Review The Baseline Structure of the Enteric Nervous System and Its Role in Parkinson’s Disease Gianfranco Natale 1,2,* , Larisa Ryskalin 1 , Gabriele Morucci 1 , Gloria Lazzeri 1, Alessandro Frati 3,4 and Francesco Fornai 1,4 1 Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, 56126 Pisa, Italy; [email protected] (L.R.); [email protected] (G.M.); [email protected] (G.L.); [email protected] (F.F.) 2 Museum of Human Anatomy “Filippo Civinini”, University of Pisa, 56126 Pisa, Italy 3 Neurosurgery Division, Human Neurosciences Department, Sapienza University of Rome, 00135 Rome, Italy; [email protected] 4 Istituto di Ricovero e Cura a Carattere Scientifico (I.R.C.C.S.) Neuromed, 86077 Pozzilli, Italy * Correspondence: [email protected] Abstract: The gastrointestinal (GI) tract is provided with a peculiar nervous network, known as the enteric nervous system (ENS), which is dedicated to the fine control of digestive functions. This forms a complex network, which includes several types of neurons, as well as glial cells. Despite extensive studies, a comprehensive classification of these neurons is still lacking. The complexity of ENS is magnified by a multiple control of the central nervous system, and bidirectional communication between various central nervous areas and the gut occurs. This lends substance to the complexity of the microbiota–gut–brain axis, which represents the network governing homeostasis through nervous, endocrine, immune, and metabolic pathways. The present manuscript is dedicated to Citation: Natale, G.; Ryskalin, L.; identifying various neuronal cytotypes belonging to ENS in baseline conditions. -
Gastrointestinal Motility Physiology
GASTROINTESTINAL MOTILITY PHYSIOLOGY JAYA PUNATI, MD DIRECTOR, PEDIATRIC GASTROINTESTINAL, NEUROMUSCULAR AND MOTILITY DISORDERS PROGRAM DIVISION OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, CHILDREN’S HOSPITAL LOS ANGELES VRINDA BHARDWAJ, MD DIVISION OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION CHILDREN’S HOSPITAL LOS ANGELES EDITED BY: CHRISTINE WAASDORP HURTADO, MD REVIEWED BY: JOSEPH CROFFIE, MD, MPH NASPGHAN PHYSIOLOGY EDUCATION SERIES SERIES EDITORS: CHRISTINE WAASDORP HURTADO, MD, MSCS, FAAP [email protected] DANIEL KAMIN, MD [email protected] CASE STUDY 1 • 14 year old female • With no significant past medical history • Presents with persistent vomiting and 20 lbs weight loss x 3 months • Initially emesis was intermittent, occurred before bedtime or soon there after, 2-3 hrs after a meal • Now occurring immediately or up to 30 minutes after a meal • Emesis consists of undigested food and is nonbloody and nonbilious • Associated with heartburn and chest discomfort 3 CASE STUDY 1 • Initial screening blood work was unremarkable • A trial of acid blockade was started with improvement in heartburn only • Antiemetic therapy with ondansetron showed no improvement • Upper endoscopy on acid blockade was normal 4 CASE STUDY 1 Differential for functional/motility disorders: • Esophageal disorders: – Achalasia – Gastroesophageal Reflux – Other esophageal dysmotility disorders • Gastric disorders: – Gastroparesis – Rumination syndrome – Gastric outlet obstruction : pyloric stricture, pyloric stenosis • -
Gastrointestinal Motility
Gastrointestinal Motility H. J. Ehrlein and M.Schemann 1. Motility of the stomach Anatomic regions of the stomach are the fundus, corpus (body), antrum and pylorus. The functional regions of the stomach do not correspond to the anatomic regions. Functionally, the stomach can be divided into the gastric reservoir and the gastric pump (Fig. 1). The gastric reservoir consists of the fundus and corpus. The gastric pump is represented by the area at which peristaltic waves occur: it includes the distal part of the corpus and the antrum. Due to different properties of the smooth muscle cells the gastric reservoir is characterised by tonic activity and the gastric pump by phasic activity. AB Gastric reservoir Fundus tonic contractions Pylorus Corpus Antrum Gastric pump phasic contractions Figure 1 . The stomach can be divided into three anatomic (A) and two functional regions (B) 1.1 Function of the gastric reservoir At the beginning of the 20 th century it was already observed that with increasing volume of the stomach the internal pressure of the stomach increases only slightly. In dogs, for instance, the increase in pressure is only 1.2 cm of water/100 ml volume. The small increase in gastric pressure indicates that the stomach does not behave like an elastic balloon but that it relaxes as it fills. Three kinds of gastric relaxation can be differentiated: a receptive, an adaptive and a feedback-relaxation of the gastric reservoir. The receptive relaxation consists of a brief relaxation during chewing and swallowing. The stimulation of mechano-receptors in the mouth and pharynx induces vago-vagal reflexes which cause a relaxation of the gastric reservoir (Fig. -
Human Body- Digestive System
Previous reading: Human Body Digestive System (Organs, Location and Function) Science, Class-7th, Rishi Valley School Next reading: Cardiovascular system Content Slide #s 1) Overview of human digestive system................................... 3-4 2) Organs of human digestive system....................................... 5-7 3) Mouth, Pharynx and Esophagus.......................................... 10-14 4) Movement of food ................................................................ 15-17 5) The Stomach.......................................................................... 19-21 6) The Small Intestine ............................................................... 22-23 7) The Large Intestine ............................................................... 24-25 8) The Gut Flora ........................................................................ 27 9) Summary of Digestive System............................................... 28 10) Common Digestive Disorders ............................................... 31-34 How to go about this module 1) Have your note book with you. You will be required to guess or answer many questions. Explain your guess with reasoning. You are required to show the work when you return to RV. 2) Move sequentially from 1st slide to last slide. Do it at your pace. 3) Many slides would ask you to sketch the figures. – Draw them neatly in a fresh, unruled page. – Put the title of the page as the slide title. – Read the entire slide and try to understand. – Copy the green shade portions in the note book. 4) -
Octreotide in Gastrointestinal Motility Disorders Gut: First Published As 10.1136/Gut.35.3 Suppl.S11 on 1 January 1994
Gut 1994; supplement 3: S11 -S 14 Sll Octreotide in gastrointestinal motility disorders Gut: first published as 10.1136/gut.35.3_Suppl.S11 on 1 January 1994. Downloaded from C Owyang Abstract Intestinal effects of octreotide in The effects of octreotide on six normal scleroderma subjects and five patients with sclero- About 50% of patients with scleroderma have derma were investigated. Changes in small bowel dysfunction.5 In such patients, intestinal motility and in plasma motilin manometry shows patterns (known as the were examined after a single injection of migrating motor complex) in the small bowel octreotide. Octreotide stimulated intense during fasting6 and this may be clinically intestinal motor activity in normal sub- manifested as intestinal pseudo-obstruction jects. Motility patterns in the scleroderma and bacterial overgrowth. These problems are patients were chaotic and non-pro- difficult to treat because standard stimulatory pagative, but, after octreotide was given, prokinetic agents are not effective in sclero- became well coordinated, aborally derma.6 We therefore recently undertook a directed, and nearly as intense as in study to determine the effects of octreotide in normal volunteers. Clinical responses and six normal subjects and in five patients with changes in breath hydrogen were also scleroderma who had abdominal pain, nausea, evaluated in the five scleroderma patients bloating, and a change in intestinal contrac- who had further treatment with octreotide tility.7 We examined the changes in intestinal at a dose of 50 pugtday subcutaneously for motility and in plasma motilin, a gastrointesti- three weeks. A reduction in symptoms of nal hormone that stimulates intestinal motor abdominal pain, nausea, vomiting, and activity, after single injections of octreotide bloating was seen. -
5-Hydroxytryptamine Andhuman Small Intestinal Motility
496 Gut 1994; 35:496-500 5-Hydroxytryptamine and human small intestinal motility: effect ofinhibiting 5-hydroxytryptamine reuptake D A Gorard, G W Libby, M J G Farthing Abstract nature is poorly understood.'0 In animals, Parenteral 5-hydroxytryptamine stimulates migrating motor complex cycling can be small intestinal motility, but the effect of con- modified by administration of 5-HT, its pre- tinuous stimulation with 5-hydroxytryptamine cursor 5-hydroxytryptophan, and its antago- on the human migrating motor complex is nists." '4 The effect of 5-HT on the migrating unknown. Using a selective 5-hydroxytrypta- motor complex in humans has not been studied. mine reuptake inhibitor, paroxetine, this study Tachyphylaxis to 5-HT given intravenously,45 investigated the effect of indirect 5-hydroxy- and associated cardiovascular and pulmonary tryptamine agonism on fasting small responses limit prolonged infusion of 5-HT in intestinal motility and transit. Eight healthy humans. The effect, however, of 5-HT agonism subjects were studied while receiving paroxe- on human small intestinal motor function might tine 30 mg daily for five days and while receiv- be alternatively investigated using a selective ing no treatment, in random order. Ambulant 5-HT reuptake inhibitor. Paroxetine selectively small intestinal motility was recorded from five inhibits the neuronal reuptake of 5-HT, increas- sensors positioned from the duodenojejunal ing the availability of synaptic 5-HT. Its ability flexure to the ileum for 16-18 hours. Paroxe- to inhibit 5-HT reuptake exceeds its ability to tine reduced the migrating motor complex inhibit noradrenaline reuptake by a factor of periodicity mean (SEM) from 81 (6) min to 67 320," making it four to five hundred times (4) min (p<005), and increased the propaga- as selective as the standard tricycic anti- tion velocity of phase III from 3-1 to 4-7 cm/ depressants imipramine and amitriptyline. -
Aandp2ch25lecture.Pdf
Chapter 25 Lecture Outline See separate PowerPoint slides for all figures and tables pre- inserted into PowerPoint without notes. Copyright © McGraw-Hill Education. Permission required for reproduction or display. 1 Introduction • Most nutrients we eat cannot be used in existing form – Must be broken down into smaller components before body can make use of them • Digestive system—acts as a disassembly line – To break down nutrients into forms that can be used by the body – To absorb them so they can be distributed to the tissues • Gastroenterology—the study of the digestive tract and the diagnosis and treatment of its disorders 25-2 General Anatomy and Digestive Processes • Expected Learning Outcomes – List the functions and major physiological processes of the digestive system. – Distinguish between mechanical and chemical digestion. – Describe the basic chemical process underlying all chemical digestion, and name the major substrates and products of this process. 25-3 General Anatomy and Digestive Processes (Continued) – List the regions of the digestive tract and the accessory organs of the digestive system. – Identify the layers of the digestive tract and describe its relationship to the peritoneum. – Describe the general neural and chemical controls over digestive function. 25-4 Digestive Function • Digestive system—organ system that processes food, extracts nutrients, and eliminates residue • Five stages of digestion – Ingestion: selective intake of food – Digestion: mechanical and chemical breakdown of food into a form usable by -
Kaplan USMLE Step 1 Prep: Which Substance Will Confirm Diagnosis?
Kaplan USMLE Step 1 prep: Which substance will confirm diagnosis? JUL 6, 2020 Staff News Writer If you’re preparing for the United States Medical Licensing Examination® (USMLE®) Step 1 exam, you might want to know which questions are most often missed by test-prep takers. Check out this example from Kaplan Medical, and read an expert explanation of the answer. Also check out all posts in this series. The AMA selected Kaplan as a preferred provider to support you in reaching your goal of passing the USMLE® or COMLEX-USA®. AMA members can save 30% on access to additional study resources, such as Kaplan’s Qbank and High-yield courses. Learn more. This month’s stumper A 55-year-old man is admitted to the hospital because of hematemesis. Measurement fasting serum gastrin levels show them to be 8-fold higher compared with a normal individual and an upper gastrointestinal endoscopy shows multiple ulcers in the duodenum. A multiple endocrine neoplasia type 1 is suspected. Administration of which of the following substances will most likely confirm the diagnosis? A. Cholecystokinin. B. Gastric inhibitory peptide. C. Motilin. D. Pentagastrin. E. Secretin. URL: https://www.ama-assn.org/residents-students/usmle/kaplan-usmle-step-1-prep-which-substance-will-confirm- diagnosis Copyright 1995 - 2021 American Medical Association. All rights reserved. The correct answer is E. Kaplan Medical explains why The patient has Zollinger-Ellison syndrome (ZES); a positive secretin stimulation test is diagnostic. Zollinger-Ellison syndrome: Caused by a gastrin-secreting tumor (gastrinoma) typically located in the pancreas or duodenal wall. -
Download The
THE ISOLATION AND PHYSIOLOGICAL ACTIONS OF GASTRIC INHIBITORY POLYPEPTIDE BY RAYMOND ARNOLD PEDERSON B.ED.; UNIVERSITY OF CALGARY, 1964 a, I A THESIS SUBMITTED IN PARTIAL FULFILMENT OF ^ THE REQUIREMENTS FOR THE DEGREE OF DOCTOR OF PHILOSOPHY IN THE DEPARTMENT OF PHYSIOLOGY WE ACCEPT THIS THESIS AS CONFORMING TO THE REQUIRED STANDARD SUPERVISOR EXTERNAL EXAMINER THE UNIVERSITY OF BRITISH COLUMBIA JUNE, 1971 In presenting this thesis in partial fulfilment of the requirements for an advanced degree at the University of British Columbia, I agree that the Library shall make it freely available for reference and study. I further agree that permission for extensive copying of this thesis for scholarly purposes may be granted by the Head of my Department or by his representatives. It is understood that copying or publication of this thesis for financial gain shall not be allowed without my written permission. Department of ~TA.y&j ¥ The University of British Columbia Vancouver 8, Canada Date 3^6/?/ ABSTRACT IT IS KNOWN THAT HUMORAL MECHANISMS FOR THE INHIBITION OF GASTRIC SECRETION AND MOTOR ACTIVITY OPERATE FROM THE DUODENUM. THE GASTROINTESTINAL HORMONES CHOLECYSTOKININ- PANCREOZYMIN (CCK-PZ) AND SECRETIN HAVE BEEN IMPLICATED AS THE HORMONES RELEASED IN SOME OF THESE PROPOSED MECHANISMS. DESPITE THE FACT THAT CCK-PZ AND SECRETIN ARE PROBABLY INVOLVED IN GASTRIC INHIBITORY MECHANISMS, THEY FALL SHORT OF FUL P LL L IN G THE ORIGINAL DEFINITION OF E N T E R 0 G A S T R 0 N E AS THE INHIBITORY PRINCIPLE RELEASED FROM THE DUODENUM BY THE PRESENCE THERE OF FAT. IMPURE PREPARATIONS OF CCK-PZ ARE KNOWN TO STIMULATE H+ SECRETION IN THE DOG WHEN GIVEN ALONE AND TO INHIBIT H+ SECRETION STIMULATED BY GASTRIN. -
Extracellular Matrix Mechanical Properties and Regulation of the Intestinal Stem Cells: When Mechanics Control Fate
cells Review Extracellular Matrix Mechanical Properties and Regulation of the Intestinal Stem Cells: When Mechanics Control Fate 1, , 1,2, 2 2 Lauriane Onfroy-Roy * y, Dimitri Hamel y, Julie Foncy , Laurent Malaquin and Audrey Ferrand 1,* 1 IRSD, Université de Toulouse, INSERM, INRA, ENVT, UPS, 31024 Toulouse, France; [email protected] 2 LAAS-CNRS, Université de Toulouse, CNRS, 31400 Toulouse, France; [email protected] (J.F.); [email protected] (L.M.) * Correspondence: [email protected] (L.O.-R.); [email protected] (A.F.); Tel.: +33-5-62-744-522 (A.F.) These authors contributed equally to the work. y Received: 31 October 2020; Accepted: 4 December 2020; Published: 7 December 2020 Abstract: Intestinal stem cells (ISC) are crucial players in colon epithelium physiology. The accurate control of their auto-renewal, proliferation and differentiation capacities provides a constant flow of regeneration, maintaining the epithelial intestinal barrier integrity. Under stress conditions, colon epithelium homeostasis in disrupted, evolving towards pathologies such as inflammatory bowel diseases or colorectal cancer. A specific environment, namely the ISC niche constituted by the surrounding mesenchymal stem cells, the factors they secrete and the extracellular matrix (ECM), tightly controls ISC homeostasis. Colon ECM exerts physical constraint on the enclosed stem cells through peculiar topography, stiffness and deformability. However, little is known on the molecular and cellular events involved in ECM regulation of the ISC phenotype and fate. To address this question, combining accurately reproduced colon ECM mechanical parameters to primary ISC cultures such as organoids is an appropriated approach. Here, we review colon ECM physical properties at physiological and pathological states and their bioengineered in vitro reproduction applications to ISC studies. -
5-HT7 Receptor Signaling: Improved Therapeutic Strategy in Gut Disorders
View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Frontiers - Publisher Connector REVIEW ARTICLE published: 11 December 2014 BEHAVIORAL NEUROSCIENCE doi: 10.3389/fnbeh.2014.00396 5-HT7 receptor signaling: improved therapeutic strategy in gut disorders Janice J. Kim and Waliul I. Khan * Department of Pathology and Molecular Medicine, Farncombe Family Digestive Health Research Institute, McMaster University, Hamilton, ON, Canada Edited by: Serotonin (5-hydroxytryptamine; 5-HT) is most commonly known for its role as a Walter Adriani, Istituto Superiore di neurotransmitter in the central nervous system (CNS). However, the majority of the body’s Sanitá, Italy 5-HT is produced in the gut by enterochromaffin (EC) cells. Alterations in 5-HT signaling Reviewed by: Yueqiang Xue, The University of have been associated with various gut disorders including inflammatory bowel disease Tennessee Health Science (IBD), irritable bowel syndrome (IBS) and enteric infections. Recently, our studies have Center, USA identified a key role for 5-HT in the pathogenesis of experimental colitis. 5-HT7 receptors Maria Cecilia Giron, University of are expressed in the gut and very recently, we have shown evidence of 5-HT receptor Padova, Italy 7 Evgeni Ponimaskin, Hannover expression on intestinal immune cells and demonstrated a key role for 5-HT7 receptors Medical School, Germany in generation of experimental colitis. This review summarizes the key findings of these Kris Chadee, University of Calgary, studies and provides a comprehensive overview of our current knowledge of the 5-HT7 Canada receptor in terms of its pathophysiological relevance and therapeutic potential in intestinal *Correspondence: inflammatory conditions, such as IBD. -
Lecture Series Gastrointestinal Tract
Lecture series Gastrointestinal tract Professor Shraddha Singh, Department of Physiology, KGMU, Lucknow INNERVATION OF GIT • 1.Intrinsic innervation-1.Myenteric/Auerbach or plexus Local 2.Submucosal/Meissners plexus 2.Extrinsic innervation-1.Parasympathetic or -2.Sympathetic Higher centre Enteric Nervous System - Lies in the wall of the gut, beginning in the esophagus and - extending all the way to the anus - controlling gastrointestinal movements and secretion. - (1) an outer plexus lying between the longitudinal and circular muscle layers, called the myenteric plexus or Auerbach’s plexus, - controls mainly the gastrointestinal movements - (2) an inner plexus, called the submucosal plexus or Meissner’s plexus, that lies in the submucosa. - controls mainly gastrointestinal secretion and local blood flow Enteric Nervous System - The myenteric plexus consists mostly of a linear chain of many interconnecting neurons that extends the entire length of the GIT - When this plexus is stimulated, its principal effects are - (1) increased tonic contraction, or “tone,” of the gut wall, - (2) increased intensity of the rhythmical contractions, - (3) slightly increased rate of the rhythmical contraction, - (4) increased velocity of conduction of excitatory waves along the gut wall, causing more rapid movement of the gut peristaltic waves. - Inhibitory transmitter - vasoactive intestinal polypeptide (VIP) - pyloric sphincter, sphincter of the ileocecal valve Enteric Nervous System - The submucosal plexus is mainly concerned with controlling function within the inner wall - local intestinal secretion, local absorption, and local contraction of the submucosal muscle - Neurotransmitters: - (1) Ach (7) substance P - (2) NE (8) VIP - (3)ATP (9) somatostatin - (4) 5 – HT (10) bombesin - (5) dopamine (11) metenkephalin - (6) cholecystokinin (12) leuenkephalin Higher centre innervation - the extrinsic sympathetic and parasympathetic fibers that connect to both the myenteric and submucosal plexuses.